
Science and Development Network
News, views and information about science, technology and the developing world
22 June 2005 | EN
Medicinal products derived from Brazil's guarana plant (Paullinia cupania) have been patented in the United States.
IRD / Uguen
The law, which defines ten offences and a range of penalties, was enacted on 8 June. It prohibits, for example, the unauthorised export of Brazilian species.
The fines vary from 200 to 50,000,000 reais (US$85 to US$20 million). Cases involving endangered species will receive double the usual fine.
Other punishments include confiscation of samples taken without permission and the suspension of sales and registrations of, and patent rights over, products derived from living organisms.
The Brazilian Institute of the Environment and Renewable Natural Resources (IBAMA) and Brazil's navy will enforce the law.
Biologist Eduardo Vélez, executive secretary of the Ministry of the Environment's Council for the Management of Genetic Patrimony says the law aims to ensure Brazil retains sovereignty over its biodiversity, whilst educating people about the importance of conserving it.
"First-time offenders that bring their activities into line with the law can have their fines reduced by up to 90 per cent, or even suspended," he says.
Fines will be used exclusively to conserve biodiversity, for instance by creating and maintaining gene banks, supporting scientific research and training personnel.
All comments are subject to approval and we reserve the right to edit comments containing inappropriate/unsuitable language. SciDev.Net holds copyright for all material posted on the website. Please see terms of use for further details.
All SciDev.Net material is free to reproduce providing that the source and author are appropriately credited. For further details see Creative Commons.
12 February 2012